SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Daniela Ferrara, MD, MSc, PhD, senior medical director for Genentech/Roche, discusses the company’s ophthalmology personalized health care program intended to improve outcomes for patien…
Author: Healio ophthalmology
Everyday solutions to reduce implicit bias in health care
NEW ORLEANS — Unconscious biases remain pervasive in everyday interactions between health care providers and patients and lead to worse outcomes for racial and gender minority populations, but several concrete actions can reduce or neutralize such tend…
Young adults with obstructive sleep apnea may be at higher risk for glaucoma
SAN FRANCISCO — Young adults with obstructive sleep apnea may experience preclinical thinning of the retinal nerve fiber layer and could be at higher risk for glaucoma, according to a speaker here.“Obstructive sleep apnea may be associated with preclin…
Filler migration can cause latent orbital complications
SAN FRANCISCO — Orbital complications after dermal filler injection may be due to inadvertent direct injection or may occur latently after filler migration, according to a retrospective review of six such cases at the American Society of Ophthalmic Pla…
When is it appropriate to bring in a consulting firm to set the management course for your practice?
Click here to read the Cover Story, “Ophthalmologists face unique practice management challenges.”Everything you need to know about business you learned in medical school. Think of your practice-business as the “patient.” All businesses, like human pat…
Several companies developing kallikrein inhibitors to treat DME
Multiple companies are developing kallikrein inhibitor therapies for various routes of delivery to provide an alternative treatment for patients with diabetic macular edema rather than the traditional treatment of anti-VEGF injections.Approximately hal…
Quality governance needed for today’s practices
Quality practice governance is critical to the long-term success of any practice. The corporate world has evolved to a structure that includes a management team reporting to a board of directors that is elected by the shareholders. The board of directo…
Ophthalmologists face unique practice management challenges
Ophthalmologists are tested with unique and difficult medical challenges every day, but practice owners and partners can take steps to address practice management challenges outside of the operating and examination rooms that can distract physicians fr…
Patient type, surgeon comfort level help guide glaucoma surgery choice
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.Surgical management of glaucoma has advanced dr…
Give the first surgeon the benefit of the doubt
Ocular surgery, particularly phacoemulsification, is delicate, challenging and often unforgiving. The margin between a success and a complication can be narrow, and while we do our best for our patients, we cannot give an absolute guarantee as to the o…
Conjunctival lesion in a middle-aged woman
A 50-year-old woman presented to an outside ophthalmologist with a 2-month history of irritation and discharge after injury to the left eye with a mascara brush. Her exam was notable for conjunctival injection and a nasal conjunctival scar. She was tre…
Combination technique lowers IOP in angle-closure glaucoma
An innovative technique combining goniosynechialysis and goniotomy achieved clinically meaningful IOP-lowering effects in patients with angle-closure glaucoma, according to a study.Goniosynechialysis has been reported with different devices but not in …
Are we underdiagnosing allergy?
Whether you are speaking at or listening to a CME lecture or a sponsored dinner program, the number of dry eye disease patients in the U.S. is given as either 16 million or 30 million patients. I have long held that both are underestimates. From my exp…
VIDEO: PanOptix trifocal lens could help grow premium market
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, John A. Hovanesian, MD, discusses how the AcrySof IQ PanOptix trifocal lens (Alcon) has been beneficial in his practice. “We can now have a really simple conversation with patients about…
VIDEO: Verana Health launches Trial Connect application
SAN FRANCISCO — At the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology meeting, Miki Kapoor, CEO of Verana Health, discusses the launch of the company’s Trial Connect program. Trial Connect is a cloud-based application a…
Artificial irises provide improved cosmetic options and better functionality for large defects
SAN FRANCISCO — While small iris defects can be treated with sutures, patients with large iris defects who have poor cosmetics and light sensitivity can be successfully treated with artificial irises, according to a speaker here.“Not only do these devi…
VIDEO: Omidria helps improve cataract surgery experience
SAN FRANCISCO — Eric Donnenfeld, MD, discusses a recent study of Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution, Omeros) at the American Academy of Ophthalmology meeting. Results found 90% of patients treated with Omidria were less l…
Bilateral visual acuity gains reported in phase 3 trial of LHON gene therapy treatment
SAN FRANCISCO — A gene therapy treatment candidate for Leber hereditary optic neuropathy bilaterally improved best corrected visual acuity during a phase 3 trial, according to a speaker here.“We saw bilateral improvement in both the treated and the sha…
APAO welcomes new member society
The Asia-Pacific Academy of Ophthalmology is pleased to welcome the Brunei Ophthalmology Society as the newest associate national member of APAO.BOS is currently under the leadership of president Dr. Helena Hurairah, who will also represent the society…
VIDEO: Bimatoprost SR shows continued IOP lowering at 1 year
SAN FRANCISCO — At the American Academy of Ophthalmology annual meeting, E. Randy Craven, MD, discusses a study showing the long-term IOP-lowering effect of the Bimatoprost SR implant from Allergan.